Nuvectis Pharma Inc (NVCT)

R&D Expenses

$19.65M

TTM · Period ending: · USD

NVCT logo

NVCT R&D Expenses

Latest reported$19.65M
NVCT R&D Expenses ($0.00 → $19.65M)
High-resolution chart · PNG

NVCT r&d expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Nuvectis Pharma Inc R&D Expenses — Annual fiscal periods (USD)
Period endingR&D Expenses (USD)
18,153,000
12,918,000
15,380,000
13,227,000
9,545,000
0
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.